SCHEMBL29409105

SCHEMBL29409105

CC(=O)C12CC(NC(=O)OCc3ccccc3)(C1)C2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
CA12 O43570 2/20 0.48
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA9 Q16790 2/20 0.48
CTSB P07858 2/20 0.47
CTSS P25774 2/20 0.47
CTSL P07711 1/20 0.47
GAA P10253 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
POLB P06746 1/20 0.43
HTT P42858 1/20 0.43
KDM1A O60341 1/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
P2RX7 Q99572 1/20 0.43
CTSK P43235 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20564912 0.88 ALDH1A1 (0.49) ALDH1A1CA12CA1CA2CA9
SCHEMBL18038887 0.87 CTSL (0.46) ALDH1A1CA12CA1CA2CA9
SCHEMBL30059309 0.84 LMNA (0.49) ALDH1A1CA12CA1CA2CA9
SCHEMBL29409067 0.83 ALDH1A1 (0.45) ALDH1A1CA12CA1CA2CA9
SCHEMBL28821026 0.82 CA12 (0.50) ALDH1A1CA12CA1CA2CA9
Hydrochloric Acid SCHEMBL29409106 0.82 KDM1A (0.45) ALDH1A1CA12CA1CA2CA9
SCHEMBL2826325 0.82 CTSL (0.46) ALDH1A1CA12CA1CA2CA9
SCHEMBL2823474 0.81 CTSB (0.46) ALDH1A1CA12CA1CA2CA9
SCHEMBL31360833 0.81 SMN1; SMN2 (0.44) ALDH1A1CA12CA1CA2CA9
SCHEMBL23671289 0.81 LMNA (0.47) ALDH1A1CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250145594-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2025-05-08 US disclosed
EP-4237413-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY Calico Life Sciences LLC (US) 2023-09-06 EP disclosed
WO-2022094244-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2022-05-05 WO disclosed
CN-114206848-A Substituted cycloalkyl compounds as modulators of integrated stress pathways 卡里科生命科学有限责任公司 2022-03-18 CN disclosed
EP-3962906-A1 SUBSTITUTED CYCLOALKYLS AS MODULATORS OF THE INTEGRATED STRESS PATHWAY Calico Life Sciences LLC (US) 2022-03-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250145594-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 ALDH1A1 2882/4885CA12 4799/4885CA1 4759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.